Development Level

Tbio 70 | 11,445
Tdark 14 | 6,588
Tchem 3 | 1,598

IMPC Phenotype

preweaning lethality, complete... 8 | 979
preweaning lethality, incomple... 5 | 499
abnormal embryo size 4 | 220
decreased vertical activity 4 | 208
abnormal behavior 3 | 298
abnormal seminal vesicle morph... 3 | 114
decreased total body fat amoun... 3 | 207
enlarged heart 3 | 210
hyperactivity 3 | 148
impaired pupillary reflex 3 | 26
increased or absent threshold ... 3 | 101
abnormal heart morphology 2 | 162
abnormal sleep behavior 2 | 70
decreased circulating amylase ... 2 | 28
decreased grip strength 2 | 116
decreased mean corpuscular hem... 2 | 50
embryonic lethality prior to o... 2 | 239
embryonic lethality prior to t... 2 | 278
enlarged lymph nodes 2 | 37
enlarged spleen 2 | 41
increased bone mineral density 2 | 72
increased circulating alkaline... 2 | 122
increased mean corpuscular hem... 2 | 96
increased mean corpuscular vol... 2 | 92
increased prepulse inhibition 2 | 32
increased startle reflex 2 | 112
abnormal QT variability 1 | 10
abnormal behavioral response t... 1 | 66
abnormal body wall morphology 1 | 9
abnormal bone structure 1 | 187
abnormal coat appearance 1 | 31
abnormal coat-hair pigmentatio... 1 | 64
abnormal craniofacial morpholo... 1 | 33
abnormal embryo turning 1 | 31
abnormal eye morphology 1 | 68
abnormal femur morphology 1 | 14
abnormal forebrain morphology 1 | 10
abnormal hindbrain morphology 1 | 10
abnormal joint morphology 1 | 23
abnormal kidney morphology 1 | 65
abnormal lymph node morphology 1 | 3
abnormal midbrain morphology 1 | 10
abnormal neural tube closure 1 | 46
abnormal placenta size 1 | 20
abnormal retinal blood vessel ... 1 | 26
abnormal sensory capabilities-... 1 | 8
abnormal skin morphology 1 | 50
abnormal spleen morphology 1 | 55
abnormal thoracic cage shape 1 | 3
absent adrenal gland 1 | 2
absent startle reflex 1 | 24
brachydactyly 1 | 19
cardiovascular system phenotyp... 1 | 36
cataract 1 | 92
cyanosis 1 | 7
decreased body length 1 | 101
decreased bone mineral content 1 | 151
decreased bone mineral density 1 | 126
decreased cardiac output 1 | 3
decreased cardiac stroke volum... 1 | 6
decreased circulating alanine ... 1 | 47
decreased circulating aspartat... 1 | 34
decreased circulating bilirubi... 1 | 19
decreased circulating glucose ... 1 | 126
decreased circulating insulin ... 1 | 76
decreased cornea thickness 1 | 2
decreased heart rate 1 | 18
decreased heart weight 1 | 27
decreased hemoglobin content 1 | 68
decreased leukocyte cell numbe... 1 | 73
decreased mean corpuscular hem... 1 | 31
decreased respiratory quotient 1 | 16
embryonic growth retardation 1 | 106
female infertility 1 | 60
hydrometra 1 | 53
hypoactivity 1 | 132
impaired glucose tolerance 1 | 75
improved glucose tolerance 1 | 79
increased body length 1 | 32
increased bone mineral content 1 | 108
increased cardiac muscle contr... 1 | 8
increased circulating amylase ... 1 | 25
increased circulating sodium l... 1 | 71
increased coping response 1 | 4
increased cornea thickness 1 | 1
increased heart weight 1 | 62
increased hematocrit 1 | 46
increased kidney weight 1 | 6
increased lean body mass 1 | 172
increased leukocyte cell numbe... 1 | 47
increased total body fat amoun... 1 | 134
limb grasping 1 | 41
male infertility 1 | 123
mydriasis 1 | 6
persistence of hyaloid vascula... 1 | 33
prenatal lethality 1 | 28
protruding tongue 1 | 3
short tibia 1 | 97
syndactyly 1 | 23

Disease

ovarian cancer 57 | 8,520
Carcinoma 51 | 11,493
osteosarcoma 50 | 7,950
medulloblastoma, large-cell 38 | 6,241
glioblastoma 37 | 5,792
atypical teratoid / rhabdoid tumor 36 | 5,112
psoriasis 36 | 6,694
ependymoma 32 | 4,679
adult high grade glioma 27 | 3,801
Astrocytoma, Pilocytic 22 | 3,081
intraductal papillary-mucinous adenoma (IPMA) 22 | 2,955
Breast cancer 21 | 3,578
group 3 medulloblastoma 21 | 4,104
primitive neuroectodermal tumor 21 | 3,035
intraductal papillary-mucinous neoplasm (IPMN) 20 | 3,291
oligodendroglioma 20 | 2,850
lung cancer 19 | 4,740
intraductal papillary-mucinous carcinoma (IPMC) 17 | 2,989
astrocytic glioma 15 | 2,597
lung carcinoma 15 | 2,843
tuberculosis 15 | 2,010
diabetes mellitus 14 | 1,728
group 4 medulloblastoma 14 | 1,855
interstitial cystitis 14 | 2,312
lung adenocarcinoma 14 | 2,716
Kidney cancer 13 | 2,613
Pick disease 13 | 1,894
invasive ductal carcinoma 13 | 2,951
malignant mesothelioma 13 | 3,232
acute quadriplegic myopathy 12 | 1,158
non-small cell lung cancer 12 | 2,890
subependymal giant cell astrocytoma 12 | 2,287
astrocytoma 11 | 1,146
pancreatic cancer 11 | 2,398
Autosomal recessive predisposition 10 | 1,442
pancreatic ductal adenocarcinoma liver metastasis 10 | 1,962
primary pancreatic ductal adenocarcinoma 10 | 1,109
Cognitive delay 9 | 608
Global developmental delay 9 | 608
Intellectual disability 9 | 1,016
Mental and motor retardation 9 | 608
Multiple myeloma 9 | 1,332
Schizophrenia 9 | 1,160
pituitary cancer 9 | 1,972
ulcerative colitis 9 | 1,819
Hermansky-Pudlak syndrome 8 | 42
acute myeloid leukemia 8 | 783
colon cancer 8 | 1,478
juvenile dermatomyositis 8 | 1,187
pediatric high grade glioma 8 | 1,064
Epilepsy 7 | 792
Neurodegenerative disease 7 | 414
progressive supranuclear palsy 7 | 676
dermatomyositis 6 | 966
ductal carcinoma in situ 6 | 1,745
hereditary spastic paraplegia 6 | 318
sonic hedgehog group medulloblastoma 6 | 467
Alzheimer's disease 5 | 658
Atopic dermatitis 5 | 952
Bipolar Disorder 5 | 666
Cancer 5 | 2,499
Down syndrome 5 | 499
Hyperreflexia 5 | 209
Liver cancer 5 | 604
Rheumatoid arthritis 5 | 1,191
Seizures 5 | 596
Tetanus 5 | 68
active Crohn's disease 5 | 922
adrenocortical carcinoma 5 | 1,428
cutaneous lupus erythematosus 5 | 1,057
cystic fibrosis 5 | 1,696
gastric carcinoma 5 | 807
Cerebellar Ataxia 4 | 304
Dull intelligence 4 | 645
Gaucher disease type 1 4 | 180
Griscelli syndrome 4 | 24
Liver Cirrhosis, Experimental 4 | 769
Low intelligence 4 | 645
Mental Retardation 4 | 645
Mental deficiency 4 | 645
Muscle hypotonia 4 | 571
Paraplegia 4 | 74
Poor school performance 4 | 645
active ulcerative colitis 4 | 764
breast carcinoma 4 | 1,638
non primary Sjogren syndrome sicca 4 | 891
Autistic Disorder 3 | 364
Endometrial cancer 3 | 311
Infantile onset 3 | 238
MAJOR AFFECTIVE DISORDER 2 3 | 22
Melanoma 3 | 711
Microcephaly 3 | 166
Multiple Sclerosis 3 | 540
Parkinson's disease 3 | 392
Polycystic ovary syndrome 3 | 360
Small head 3 | 374
esophageal adenocarcinoma 3 | 737
hepatocellular carcinoma 3 | 547
pancreatic carcinoma 3 | 562
spina bifida 3 | 1,074

Tissue

Digestive Tract 87 | 17,369
Endocrine System 87 | 18,159
Female tissues 87 | 17,400
Liver and Pancreas 87 | 16,750
Male tissues 87 | 17,142
Respiratory system 87 | 16,393
Skin and soft tissues 87 | 17,230
Urinary Tract 87 | 16,678
Blood and immune system 86 | 16,909
Nervous System 86 | 16,725
Cardiovascular System 83 | 15,192

Target Family

Non-IDG 67 | 12,091
Enzyme 16 | 4,145
Kinase 2 | 634
Epigenetic 1 | 242
Ion Channel 1 | 344

GO Process

vesicle-mediated transport 87 | 87
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
Arf-GAP with Rho-GAP domain, ANK repeat and PH domain-containing protein 3 ARAP3 Tbio Non-IDG -0.96067 13.8 85
Copine-1 CPNE1 Tbio Non-IDG -1.04880 11.6 151
Vesicle transport protein GOT1B GOLT1B Tdark Non-IDG -0.71600 5.85 47
Vesicle transport protein SFT2A SFT2D1 Tdark Non-IDG 0.12 0.50 9
Copine-6 CPNE6 Tbio Non-IDG -0.79740 6.43 129
Charged multivesicular body protein 1a CHMP1A Tbio Non-IDG -1.15571 14.9 161
Spectrin beta chain, non-erythrocytic 2 SPTBN2 Tbio Non-IDG -1.73436 53.8 237
ADP-ribosylation factor-like protein 17 ARL17A Tdark Enzyme 0.30 0.50 28
Cat eye syndrome critical region protein 2 CECR2 Tchem Epigenetic -2.17030 147.0 44
Kinesin heavy chain isoform 5A KIF5A Tbio Non-IDG -1.69131 48.4 170